Q1 Starts With $536,000 in Deferred Revenue From

New Post Public Reply Private Reply Replies (0) Message Board Keep
BielyMonster
468
Post of 9,417
Q1 Starts With $536,000 in Deferred Revenue

From Q4.

May 15th are Q1 Financials.

Estimated at least 50-60% toward Profitability.

Keep in mind that order will need refilling and all the other growth.

Most of that order is Mundipharma, owned by Purdue.

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼